Interferoncontaining drugs: clinical, pharmacological, and immunological points of their use for respiratory diseases treatment

Nowadays pharmacological group classified by the ATX L03AX code as immunostimulants is demand among doctors of various specialties. The main area application such drugs infectious respiratory viral processes, which are associated not only with pathogenetic action viruses, but also a high risk bacterial complications. Thus, practitioner faced task preventing complications and choosing an immunomodulatory drug most pronounced pharmacodynamic properties in this regard. In Russia, there many belonging to immunomodulators different mechanisms end immunological points application. emphasis made on effect systems both innate adaptive immunity. At same time, severity one other immune system that strong enough may differ, requires special attention from doctor when particular situation. A place used for diseases occupied interferoncontaining contain interferon alfa-2b (IFN-a2b). addition, combination IFN-a2b immunoglobulin complex, increases effectiveness treatment inflammatory diseases. article describes theoretical practical aspects administration combined pediatric practice presents own experimental studies.